Can Corza bust up Medtech’s surgical supply monopolies? Why Zimmer’s spin out is only the beginning
In this week’s episode learn how Greg Lucier, executive chairman of Corza Medical, intends to use his experience and GTCR's capital to build a surgical supply company that he says will challenge medtech's (almost) monopolies.
Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry.
Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company.
Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems.
Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others.
Subscribe now on your favorite podcast player!
Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry.
Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company.
Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems.
Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others.
Subscribe now on your favorite podcast player!
Activity